Description: Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the research, development, manufacture, and wholesale of active pharmaceutical ingredients (APIs) in Taiwan and the United States. It offers API products, which include immunosuppressant, oncology, cardiovascular, and other products, as well as peptide drugs. The company also develops bulk pharmaceutical products, such as anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular drugs, skeletal, muscle relaxants, hypolipaemics, antineoplastic, antihyperlipedemias, and immunosuppressant products, as well as provides research and development, and contract manufacturing services to new drug developers and generic drug companies. The company was formerly known as China Chemical Synthesis Industry Co., Ltd. Chunghwa Chemical Synthesis & Biotech Co., Ltd. was founded in 1964 and is headquartered in New Taipei City, Taiwan.
Home Page: www.ccsb.com.tw
No.1, Dongxing Street
New Taipei City,
23850
Taiwan
Phone:
886 2 8684 3318
Officers
| Name | Title |
|---|---|
| Mr. Chung-Hsin Huang | Pres & GM |
| Mr. Kuan-Chieh Wang | Mang. of Fin. & Treasury Dept., and Head of Accounting & Corp. Governance |
| Mr. Jun-Jie Liao | Mang. of Human Resource Office |
| Mr. Chao-Sheng Hong | Chief Auditor |
Exchange: TW
Country: TW
Currency: New Taiwan Dollar (NT$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 9.694 |
| Price-to-Book MRQ: | 1.5632 |
| Price-to-Sales TTM: | 2.3689 |
| IPO Date: | 2009-12-10 |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |